USD 0.37
(2.78%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -20.76 Million | -26.47 Million | 64.69 Million | 26.28 Million | 17.38 Million | 41.21 Million |
Net Income | -65.29 Million | -894.21 Million | -59.57 Million | -16.42 Million | 56.1 Million | 38.61 Million |
Depreciation & Amortization | 9.79 Million | 37 Million | 23.27 Million | 12.1 Million | 6.63 Million | 5.36 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 5.68 Million | 15.2 Million | 53.93 Million | 19.41 Million | - | - |
Change in working capital | -7.05 Million | 984 Thousand | 21.81 Million | -29.75 Million | -66.45 Million | -27.09 Million |
Other non-cash items | 36.1 Million | 814.54 Million | 25.24 Million | 40.94 Million | 21.1 Million | 24.33 Million |
Investing Cash Flow | -176 Thousand | -38.47 Million | -291.2 Million | -121.33 Million | -37.3 Million | -131.31 Million |
Investments in PPE | - | -158 Thousand | -57.94 Million | -10.84 Million | -13.46 Million | -1.8 Million |
Acquisitions | - | 315 Thousand | - | 1.07 Million | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -176 Thousand | -38.63 Million | -233.26 Million | -111.56 Million | -23.84 Million | -129.5 Million |
Financing Cash Flow | 23.09 Million | 11.33 Million | 259.84 Million | 97.75 Million | 11.8 Million | 107.52 Million |
Debt repayment | -13.72 Million | 20.43 Million | -15.02 Million | 2.83 Million | 48 Million | -2.4 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | -1.27 Million | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 9.36 Million | -9.09 Million | 276.14 Million | 94.92 Million | -36.2 Million | 109.92 Million |
Accounts receivables | -15.48 Million | 2.48 Million | 51.96 Million | -25.9 Million | -67.35 Million | -31.49 Million |
Accounts payables | 3.35 Million | - | - | - | - | - |
Inventory | 778 Thousand | -1.11 Million | -6.35 Million | 859 Thousand | -116 Thousand | -575 Thousand |
Other working capital | 7.66 Million | -386 Thousand | -23.79 Million | -4.7 Million | 1.02 Million | 4.97 Million |
Cash at beginning of period | 5.42 Million | 59.04 Million | 25.71 Million | 23.01 Million | 31.12 Million | - |
Cash at end of period | 7.57 Million | 5.42 Million | 59.04 Million | 25.71 Million | 23.01 Million | 31.12 Million |
Capital Expenditure | - | -158 Thousand | -57.94 Million | -10.84 Million | -13.46 Million | -1.8 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 2.14 Million | -53.62 Million | 33.32 Million | 2.7 Million | -8.11 Million | 31.12 Million |
Free Cash Flow | -20.76 Million | -26.63 Million | 6.74 Million | 15.44 Million | 3.92 Million | 39.41 Million |
Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -36.42 Million | -65.29 Million | -36.42 Million | 20.3 Million | 3.77 Million | -890.43 Million |
Depreciation & Amortization | - | 9.79 Million | - | - | - | 37.02 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 1.74 Million | 5.68 Million | 1.74 Million | 1.1 Million | 1.09 Million | 53.93 Million |
Change in working capital | - | -7.05 Million | - | - | - | 2.12 Million |
Other non-cash items | 34.67 Million | 36.1 Million | 34.67 Million | -21.41 Million | -4.87 Million | 809.6 Million |
Investing Cash Flow | - | -176 Thousand | - | - | - | -38.47 Million |
Investments in PPE | - | - | - | - | - | -42.74 Million |
Acquisitions | - | - | - | - | - | 315 Thousand |
Investment purchases | - | - | - | - | - | -1 Million |
Sales/Maturities of investments | - | - | - | - | - | 261 Thousand |
Other Investing Activities | - | -176 Thousand | - | - | - | 3.69 Million |
Financing Cash Flow | - | 23.09 Million | - | - | - | 11.33 Million |
Debt repayment | - | -13.72 Million | - | - | - | -47.44 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | -1.27 Million |
Common Stock Issuance | - | - | - | - | - | 828 Thousand |
Other Financing Activities | - | 9.36 Million | - | - | - | 57.95 Million |
Accounts receivables | - | -15.48 Million | - | - | - | 2.48 Million |
Accounts payables | - | - | - | - | - | 4.49 Million |
Inventory | - | 778 Thousand | - | - | - | -1.11 Million |
Other working capital | - | 7.66 Million | - | - | - | -3.74 Million |
Cash at beginning of period | - | 5.42 Million | - | - | - | 59.04 Million |
Cash at end of period | - | 7.57 Million | - | - | - | 5.42 Million |
Capital Expenditure | - | - | - | - | - | -42.74 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | 2.14 Million | - | - | - | -53.62 Million |
Free Cash Flow | - | -20.76 Million | - | - | - | -69.22 Million |
CRGY
SBCL
OATN
GBIM
NDBKY
UNICHEMLAB